Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase IC Study of Safety and PK of SQ109 300mg Daily

This study has been completed.
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID) Identifier:
First received: November 18, 2010
Last updated: May 10, 2013
Last verified: May 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2011
  Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)